Acute Coronary Syndromes
News
Prostate cancer: Men with comorbidity may be better off with no ADT
Key clinical point: Forgoing androgen deprivation therapy cuts rather than raises overall and cardiac mortality in certain patients with prostate...
Commentary
Empagliflozin’s triumph respins FDA’s diabetes drug mandate
Conference Coverage
EASD: SGLT2 inhibitor empagliflozin cuts CV risk in patients with type 2 diabetes
Key clinical point: Empagliflozin reduced cardiovascular risk in patients with type 2 diabetes who were at high cardiovascular risk, making it the...
Conference Coverage
ESC: Nonobstructive CAD spells below-average mortality
Key clinical point: Rates of acute MI and all-cause mortality in patients with stable angina pectoris but no obstructive CAD are significantly...
Conference Coverage
ESC: Statins reduce postoperative noncardiac surgery event rates
Key clinical point: Statin therapy, given the week before a host of noncardiac surgical procedures, reduced the postoperative risk for death and...
Conference Coverage
ESC: Celecoxib safety study may soothe cardio concerns
Nonselective NSAIDs weren’t significantly safer than celecoxib in arthritis patients without confirmed cardiovascular disease.
Conference Coverage
ESC: Bivalirudin no better than unfractionated heparin in PCI
Key clinical point: Compared with unfractionated heparin, bivalirudin did not reduce the MACE rate in patients with ACS who were candidates for...
Conference Coverage
Benznidazole: No clinical impact on Chagas cardiomyopathy
Among patients with Chagas cardiomyopathy, trypanocidal therapy with benznidazole significantly reduced serum parasite detection but did not...
News
Heart attack patients more likely to die after ambulances are diverted
The study adds to a growing body of research nationally showing that temporary diversions of ambulances from the nearest hospital can harm...
News
ESC: Aldosterone blockade fails to fly for early MI in ALBATROSS
Giving aldosterone antagonists to acute MI patients without heart failure didn’t improve clinical outcomes in the ALBATROSS trial.
News
Heart attack risk rises in first month after knee, hip arthroplasty
Key clinical point: Total knee and hip arthroplasty were associated with a significantly increased risk of myocardial infarction in the first...